Download PDF
Thromb Haemost 1975; 33(03): 632-639
DOI: 10.1055/s-0038-1647858
International Committee on Thrombosis and Haemostasis Task Force
Schattauer GmbH

Studies on the Thrombogenicity of Scottish Factor IX Concentrates in Dogs[*]

John D Cash
1   South-East Scotland Regional Blood Transfusion Centre, Royal Infirmary and Scottish National Blood Transfusion Service Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh
,
Rodger G Dalton
1   South-East Scotland Regional Blood Transfusion Centre, Royal Infirmary and Scottish National Blood Transfusion Service Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh
,
Sarah Middleton
1   South-East Scotland Regional Blood Transfusion Centre, Royal Infirmary and Scottish National Blood Transfusion Service Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh
,
James K Smith
1   South-East Scotland Regional Blood Transfusion Centre, Royal Infirmary and Scottish National Blood Transfusion Service Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh
› Author Affiliations
Further Information

Publication History

Received 30 January 1975

accepted 30 January 1975

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Task Force Report


 

  • References

  • 1 Bidwell E, Booth J. M, Dike G. W. R, Denson K. W. E. The preparation for therapeutic use of a concentrate of factor IX containing also factors II, VII and X. British Journal of Haematology 1967; 13: 568
    CrossrefPubMedGoogle Scholar
  • 2 Bruning P. F, Loeliger E. A. Prothrombal: A new concentrate of human prothrombin complex for clinical use. British Journal of Haematology 1971; 21: 377
    CrossrefPubMedGoogle Scholar
  • 3 Dacie J. V, Lewis S. M. Practical Haematology . 3rd Edition. London: Churchill; 1963: 51
  • 4 Davidson S. Personal Communication. 1972
    Google Scholar
  • 5 Dike G. W. R, Bidwell E, Rizza C. R. The preparation and clinical use of a new concentrate containing factor IX, prothrombin and factor X, and of a separate concentrate containing factor VII. British Journal of Haematology 1975; 22: 469
    PubMedGoogle Scholar
  • 6 Edson J. R. Prothrombin complex concentrates and thromboses (letter). New England Journal of Medicine 1974; 290: 403
    CrossrefPubMedGoogle Scholar
  • 7 Ellis B.C, Stransky A. A quick and accurate method for the determination of fibrinogen in plasma. Journal of Laboratory and Clinical Medicine 1961; 58: 477
    PubMedGoogle Scholar
  • 8 Gilchrist G. S, Ekert H, Shanbrom E, Hammond D. Evaluation of a new concentrate for the treatment of factor IX deficiency. New England Journal of Medicine 1969; 280: 291
    CrossrefPubMedGoogle Scholar
  • 9 Hardisty R. M, Ingram G. I. C. Bleeding Disorders: Investigation and management . Oxford: Blackwell Scientific Publication Ltd.; 1965: 277
    Google Scholar
  • 10 Hoq M. S, Das P. C. Preparation of human cells for the assay of serum F.D.P. using T.U.C.H.I.I. Scandinavian Journal of Haematology Suppl 1971; 13: 101
    PubMedGoogle Scholar
  • 11 Johnson A. J, Newman J, Semarn S, Middleton S, Smith J. K. Removal of hepatitis-B antigen (HB-Ag) from coagulation factor II, VII, IX and X concentrates for clinical use. IVth International Congress Thrombosis and Haemostasis Vienna,June 1973, Abstract. 1973
    Google Scholar
  • 12 Josso F, Ménaché D, Steinbuch M, Blatrix C, Soulier J. P. The P.P.S.B. fraction. Bibliotheca Haematologica (Basel) 1970; 34: 18
    PubMedGoogle Scholar
  • 13 Kasper C. K. Postoperative thrombosis in haemophilia B. New England Medical Journal 1973; 289: 160
    PubMedGoogle Scholar
  • 14 Kierulf P, Godal H. C. Fibrinaemia in medical patients screened by the ethanol gelation test. Acta Medica Scandinavica 1971; 190: 185
    PubMedGoogle Scholar
  • 15 Marchesi S. L, Burney R. Prothrombin complex concentrates and thromboses (letter). New England Journal of Medicine 1974; 290: 403
    CrossrefPubMedGoogle Scholar
  • 16 Ménaché D, Fauvert R, Soulier J. P. Utilisation en hépatologie d’une fraction contenant ea prothrombine, le compleze proconvertine – facteur Stuart et le facteur anti-hémophilique B (P.P.B.). Pathologie et Biologie 1959; 1: 2515
    PubMedGoogle Scholar
  • 17 Middleton S. M, Bennet I. H, Smith J. K. A therapeutic concentrate of coagulation factors II, IX and X from citrated factor VIII depleted plasma. Vox sanguinis 1973; 24: 441
    PubMedGoogle Scholar
  • 18 Nilsson I. M, Ahlberg A, Bjorlin G. Clinical experience with a Swedish factor IX concentrate. Acta Medica Scandinavica 1971; 190: 257
    PubMedGoogle Scholar
  • 19 Soulier J. P, Blatrix C, Steinbuch M. Fractions “coagulantes” contenant le facteurs de coagulation absorbables par le phosphate tricalcique. Presse médical 1964; 72: 1223
    PubMedGoogle Scholar
  • 20 Steinberg M, Dreiling B. J. Vascular lesions in haemophilia B. New England Journal of Medicine 1973; 289: 592
    PubMedGoogle Scholar
  • 21 Triantaphyllopoulous D. C. Intravascular coagulation following injection of prothrombin complex. American Journal of Clinical Pathology 1972; 57: 603
    CrossrefPubMedGoogle Scholar
  • 22 Tullis J. L, Breen F. Christmas factor concentrates; the clinical use of several preparations. Bibliotheca haematologica (Basel) 1970; 34: 40
    PubMedGoogle Scholar